This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a Firm-Fixed price purchase order to Affymetrix, Inc. (Large Business) Santa Clara, CA 95051-0704 on a sole source basis to procure various patented reagents that are used Critical Care Medicine Department protocols. Affymetrix, Inc, is the only known vendor that manufactures the GeneChip technology which has been patented and in use since the late 1990s . The reagents that will be in use only work with the Affymetrix equipment that is housed in the Critical Care Medicine Department. The GeneChip reagents will be used with the Affymextrix equipment in order to provide continued results of the current ALI, PHT, Anthrax, HIV and pneumocystis protocols in place. No other company can provide the supplies at this time due to consistency and protocols. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Ivan Jones, Contract Specialist,
[email protected] by the due date and time marked in this notice.